A new trading day began on Monday, with Kyverna Therapeutics Inc (NASDAQ: KYTX) stock price up 16.40% from the previous day of trading, before settling in for the closing price of $4.39. KYTX’s price has ranged from $3.92 to $35.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -37.90% over the last five years. Meanwhile, its annual earnings per share averaged 96.32%. With a float of $18.69 million, this company’s outstanding shares have now reached $43.12 million.
The firm has a total of 96 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Kyverna Therapeutics Inc (KYTX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Kyverna Therapeutics Inc is 56.68%, while institutional ownership is 31.26%. The most recent insider transaction that took place on Feb 12 ’24, was worth 5,568,992. In this transaction 10% Owner of this company bought 253,136 shares at a rate of $22.00, taking the stock ownership to the 252,553 shares. Before that another transaction happened on Feb 12 ’24, when Company’s 10% Owner bought 450,000 for $22.00, making the entire transaction worth $9,900,000. This insider now owns 3,163,868 shares in total.
Kyverna Therapeutics Inc (KYTX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 96.32% per share during the next fiscal year.
Kyverna Therapeutics Inc (NASDAQ: KYTX) Trading Performance Indicators
Here are Kyverna Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.07, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -3.69 in one year’s time.
Technical Analysis of Kyverna Therapeutics Inc (KYTX)
Analysing the last 5-days average volume posted by the [Kyverna Therapeutics Inc, KYTX], we can find that recorded value of 0.38 million was lower than the volume posted last year of 0.46 million. As of the previous 9 days, the stock’s Stochastic %D was 38.27%. Additionally, its Average True Range was 0.42.
During the past 100 days, Kyverna Therapeutics Inc’s (KYTX) raw stochastic average was set at 15.91%, which indicates a significant decrease from 70.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 102.88% in the past 14 days, which was higher than the 84.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.13, while its 200-day Moving Average is $12.85. Now, the first resistance to watch is $5.41. This is followed by the second major resistance level at $5.70. The third major resistance level sits at $6.18. If the price goes on to break the first support level at $4.64, it is likely to go to the next support level at $4.16. Now, if the price goes above the second support level, the third support stands at $3.87.
Kyverna Therapeutics Inc (NASDAQ: KYTX) Key Stats
With a market capitalization of 242.72 million, the company has a total of 43,172K Shares Outstanding. Currently, annual sales are 0 K while annual income is -60,370 K. The company’s previous quarter sales were 0 K while its latest quarter income was -34,490 K.
